booksilder

Want to learn more?

myARwin has been developed by Takeda, in collaboration with hematology nurses, patients, caregivers and patient associations. All coming together to support the challenges patients may face in the self-infusion process. If you want to know more about how myARwin can benefit your patients and you want to book a live demo, please contact:


Carolina Brünner, PhD
Medical Advisor, Takeda
Mobile +46-73-663 38 03
Email carolina.brunner@takeda.com

 
 
mobile
Meet the team behind myARwin
  • ” Working on a tool that will create real value for patients has been a tremendous highlight for me. I believe this app will make a big difference for patients and their families.”

  • ” Being part of this co-creation project together with the expert nurses has made me realize how much better tools and solutions for patients can be when we collaborate and fully utilize the different competences represented."

  • "It has been great to work together with Nordic healthcare professionals and patients groups to develop this solution, and also explore how advanced technologies like augmented reality can be utilized. The co-creation approach is important for Takeda to build value-based partnerships in healthcare ecosystems."

  • ”It has been very inspiring working on a tool, that I think will be helpful and appreciated by our patients, self-infusion is so important to them.”

  • ” The opportunity to create something new, that will be for the benefit of the patient and their families is always a privilege. To be doing this with Nordic colleagues tackling similar issues makes this even better, a truly powerful experience.”

  • ” The app is a fantastic tool that combines evidence based nursing skills with modern technology. I believe it will give patients with bleeding disorders both support and increased independence. It´s been great working with everyone on this project knowing we create something that will make a difference for the patients.”

  • "I am very grateful that I got to examine my own practise through the eyes of my Nordic colleagues. This has truly been a Nordic collaboration with the interest of our patients at heart.”